Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019)

Hardy J.; Baggott C.; Fingleton J.

首页> 外文期刊>The Lancet >Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019)

【24h】

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019)

机译：Budesonide-formoterol refiever治疗与维护Budesonide加上特布尔氨酸救济疗法加上患有轻度至中度哮喘的成人（实用）：52周，开放式标签，多方形，优势，随机对照试验（Vol 394，PG 919,2019）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet》 |2020年第10234期|共1页
作者
Hardy J.; Baggott C.; Fingleton J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献

1. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019) [J] . Hardy J., Baggott C., Fingleton J. The Lancet . 2020,第10234期

机译：Budesonide-formoterol refiever治疗与维护Budesonide加上特布尔氨酸救济疗法加上患有轻度至中度哮喘的成人（实用）：52周，开放式标签，多方形，优势，随机对照试验（Vol 394，PG 919,2019）
2. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy [J] . Roland Buhl, Piotr Kuna, Matthew J Peters, Respiratory Research . 2012,第1期

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：对两项随机对照研究的探索性分析，与标准疗法进行了比较
3. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy [J] . Roland Buhl, Piotr Kuna, Matthew J Peters, Respiratory Research . 2012,第1期

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：对两项随机对照研究的探索性分析，与标准疗法进行了比较
4. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised controlled studies with comparisons to standard therapy [O] . Roland Buhl, Piotr Kuna, Matthew J Peters, 2012

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：与标准疗法比较的两项随机对照研究的探索性分析
5. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy [O] . Roland Buhl, Piotr Kuna, Matthew J Peters, 2012

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：对两项随机对照研究的探索性分析，与标准疗法进行了比较

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019)

著录项

相似文献

相关主题

期刊订阅